Dr. Robert M. Feldman, MD

Dr. Feldman practices at Memorial Hermann - Texas Medical Center - HOPD (6400 Fannin St 16th Floor) in Houston, Texas.

Dr. Feldman's NPI, 1093796864, was assigned on November 9, 2005. Dr. Feldman graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1986. Dr. Feldman holds Texas license J7484.

Dr. Feldman's primary practice is Memorial Hermann - Texas Medical Center - HOPD (6400 Fannin St 16th Floor), at 6400 Fannin St 16th Floor, Houston, TX 77030.

Dr. Feldman's primary practice is Memorial Hermann - Texas Medical Center - HOPD (6400 Fannin St 16th Floor) in Houston, Texas. Dr. Feldman is also affiliated with Harris Health Ben Taub Hospital. The medical group on file is UTHealth Houston Neurosciences, Texas Medical Center. Dmand AI also links Dr. Feldman to 2 more medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feldman practices, 4 sites in all. Vendor and product names are available with a free account.

Glaucoma specialist is Dr. Feldman's primary specialty in the NPI Registry, under taxonomy code 207WX0009X. Dr. Feldman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Feldman's licenses on file in 2 states: Texas and California.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, eyelid inflammation, glaucoma, glaucoma surgery, hereditary corneal conditions and hypertensive retinopathy among the conditions Dr. Feldman treats.

CMS data shows 1,483 Medicare services from Dr. Feldman across 19 procedure codes in 2024, for 378 Medicare patients. Medicare paid $102,866 for them.

CMS counts 378 Medicare patients who saw Dr. Feldman in 2024. The largest group is 75 to 84, with 161 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Feldman's median patient age at 70, with 60% women.

In 2024, Dr. Feldman wrote 2,728 Medicare Part D claims for 482 patients. 51% of them were for generic drugs. CMS names the drug for 2,643 of them, across 27 drugs with 11 or more claims each, at $362,610 in total drug cost. In 2023, CMS named 2,202 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Feldman for performance year 2024, reported as part of a group. Dr. Feldman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 113 papers to Dr. Feldman, published from 2008 to 2024. 2016 was the busiest year, with 10. The most frequent topics are Intraocular Pressure, Glaucoma and Glaucoma, Open-Angle. Dr. Feldman has published most often in J Glaucoma. Dr. Feldman's most frequent co-authors are Nicholas P. Bell, MD, Lauren Sasha Blieden, MD and Sherif Mostafa El-Harazi, MD, MPH.

Dmand AI links Dr. Feldman to 6 clinical trials. Conditions studied include Glaucoma, Glaucoma, Open-Angle and Diabetic Retinopathy. InnFocus Inc. sponsors the most, 2.

CMS Open Payments shows 203 general payments to Dr. Feldman from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Alcon Laboratories Inc paid the most, $32,315.

Dmand AI lists 3 awards for Dr. Feldman, most recently CMS Stage 1 2012 in 2012.

Dr. Feldman graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1986. Dr. Feldman is a member of AAO.

Dr. Feldman is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.